Pure Financial Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67K Sell
10,874
-69
-0.6% -$573 ﹤0.01% 566
2025
Q4
$114K Buy
10,943
+64
+0.6% +$642 ﹤0.01% 530
2025
Q3
$97.8K Buy
10,879
+20
+0.2% +$176 ﹤0.01% 491
2025
Q2
$141K Buy
10,859
+50
+0.5% +$752 ﹤0.01% 462
2025
Q1
$273K Sell
10,809
-3,603
-25% -$107K 0.01% 328
2024
Q4
$495K Hold
14,412
0.01% 218
2024
Q3
$712K Hold
14,412
0.02% 181
2024
Q2
$867K Sell
14,412
-3,980
-22% -$227K 0.02% 154
2024
Q1
$949K Buy
+18,392
New +$903K 0.03% 148

Other funds holding RXST

Pure Financial Advisors's RXST Position: Q1 2026 in Review

Pure Financial Advisors reduced its RxSight (RXST) stake by 0.63% in Q1 2026, selling an estimated $573 and leaving 10,874 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Pure Financial Advisors first reported a position in RXST in Q1 2024 and has held it in 9 quarters since. The position peaked at $949K in Q1 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Pure Financial Advisors held 10,874 shares of RxSight worth $67K as of Q1 2026.
  • Pure Financial Advisors sold 69 RxSight shares in Q1 2026, an estimated $573.
  • RxSight made up ﹤0.01% of Pure Financial Advisors's portfolio in Q1 2026, its #566 holding.
  • Pure Financial Advisors first reported a position in RxSight in Q1 2024 and has held it in 9 quarters since.
  • Pure Financial Advisors's RxSight position peaked at $949K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Pure Financial Advisors's 13F filing for Q1 2026, filed 10 Apr 2026.